Ovarian Cancer Clinical Trials

Showing 641-660 of 1,019 trials

Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer

NCT00692900

The purpose of this study is to determine the safest and maximum tolerated dosing regimens for intraperitoneal oxaliplatin with intravenous docetaxel and intravenous oxaliplatin with intraperitoneal docetaxel for recurrent ovarian, primary peritoneal, or fallopian tube cancer.

Ovarian CancerPeritoneal CancerFallopian Tube Cancer

University of Pittsburgh25 participantsStarted Dec 2008

Pittsburgh, Pennsylvania, United States

COMPLETEDNA

Lymphadenectomy In Ovarian Neoplasms

NCT00712218

To assess the efficacy of systematic pelvic and para-aortic lymphadenectomy in patients with advanced ovarian cancer and intra-abdominal complete debulking. Secondary: progression-free survival, complications and quality of life; Exploratory: Role of number of resected lymph nodes for primary and secondary objectives

Ovarian Cancer

Philipps University Marburg640 participantsStarted Dec 2008

Graz, Austria • Innsbruck, Austria • Vienna, Austria +56 more locations

Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer

Lymphadenectomy In Ovarian Neoplasms

Related Searches

HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma

Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention

Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage

Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer

Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery

Metastatic Tumor Cell Trap Device in Patients With Advanced Ovarian Cancer

Diffusion-weighted Imaging Study in Cancer of the Ovary

Genetic Mutation in Epithelial Ovarian Cancer

Methods in Education for Breast Cancer Genetics

Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer

18F-CP18 Imaging Studies for Cancer Treatment With Birinapant

LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer

Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients

Sentinel Lymph Node in Early Ovarian Cancer

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer